Free Trial

Uxin (UXIN) Financials

Uxin logo
$4.59 -0.11 (-2.34%)
Closing price 04/28/2025 03:59 PM Eastern
Extended Trading
$4.35 -0.24 (-5.23%)
As of 04/28/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Uxin

Annual Income Statements for Uxin

This table shows Uxin's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
-255 -579 -347 -286 -64 -23 -130 -337
Consolidated Net Income / (Loss)
-200 -422 -224 -286 -64 -23 -20 -51
Net Income / (Loss) Continuing Operations
-200 -195 -197 -191 -109 -23 -21 -53
Total Pre-Tax Income
-198 -195 -197 -195 -111 -23 -21 -52
Total Operating Income
-180 -60 -362 -186 -84 -44 -52 -43
Total Gross Profit
42 33 35 129 -2.48 7.53 3.70 11
Total Revenue
118 47 96 228 100 258 300 190
Operating Revenue
118 47 96 228 100 258 300 190
Total Cost of Revenue
76 14 61 99 102 251 296 179
Operating Cost of Revenue
76 14 61 99 102 251 296 179
Total Operating Expenses
221 93 396 315 82 52 56 54
Selling, General & Admin Expense
84 60 156 58 42 24 24 25
Marketing Expense
114 28 217 170 52 35 34 28
Research & Development Expense
24 0.00 18 20 11 5.71 5.49 4.68
Other Operating Expenses / (Income)
-0.28 5.56 5.27 67 -24 -13 -8.18 -2.86
Total Other Income / (Expense), net
-19 -136 165 -9.81 -27 21 31 -8.69
Interest Expense
- 0.03 9.30 16 15 6.50 3.50 8.67
Interest & Investment Income
0.10 0.34 3.57 0.78 6.87 30 35 0.02
Other Income / (Expense), net
-19 -136 171 5.57 -20 -2.06 -1.39 -0.04
Income Tax Expense
0.26 0.03 0.24 -0.37 0.01 0.04 0.05 0.04
Other Gains / (Losses), net
-1.38 0.55 0.38 4.34 2.38 0.05 -0.01 -0.82
Other Adjustments to Consolidated Net Income / (Loss)
- - - - - 0.00 1.51 1.66
Preferred Stock Dividends Declared
60 161 126 - 0.00 0.00 110 285
Net Income / (Loss) Attributable to Noncontrolling Interest
-5.04 -3.87 -4.59 -0.42 -0.00 0.00 -0.00 0.39
Basic Earnings per Share
($36.11) ($46.52) - - - ($0.02) ($0.10) ($0.02)
Weighted Average Basic Shares Outstanding
49.17B 49.32M 477.85M 886.61M 1.10B 1.17B 1.34B 2.19B
Diluted Earnings per Share
($36.11) ($29.99) - - - ($0.33) ($0.10) ($0.02)
Weighted Average Diluted Shares Outstanding
49.17B 49.32M 477.85M 886.61M 1.33B 1.35B 1.34B 2.19B
Weighted Average Basic & Diluted Shares Outstanding
49.17B 49.32M 477.85M 127.30M 1.13B 1.19B 1.41B 56.40B

Quarterly Income Statements for Uxin

No quarterly income statements for Uxin are available.


Annual Cash Flow Statements for Uxin

This table details how cash moves in and out of Uxin's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2021 2022 2023 2024
Net Change in Cash & Equivalents
-112 134 272 -230 -86 -15 -6.26 -9.61
Net Cash From Operating Activities
-95 -281 -332 -171 -171 -133 -37 -36
Net Cash From Continuing Operating Activities
-95 -281 -193 -171 -171 -133 -37 -36
Net Income / (Loss) Continuing Operations
-200 -422 -224 -286 -64 -23 -20 -51
Consolidated Net Income / (Loss)
-200 -422 -224 -286 -64 -23 -20 -51
Depreciation Expense
7.07 10 13 13 7.06 2.25 1.94 1.70
Amortization Expense
0.46 0.56 0.82 12 1.68 2.43 2.55 3.96
Non-Cash Adjustments To Reconcile Net Income
122 2.80 -8.14 205 -22 -25 -33 11
Changes in Operating Assets and Liabilities, net
-25 126 25 -116 -93 -90 12 -2.18
Net Cash From Investing Activities
1.34 -90 -157 -70 67 -2.65 -4.66 -1.57
Net Cash From Continuing Investing Activities
1.34 -90 -157 -70 67 -2.65 -4.66 -1.57
Purchase of Property, Plant & Equipment
-14 -12 -19 -6.72 -0.06 -2.94 -4.83 -1.76
Sale of Property, Plant & Equipment
1.65 0.14 1.13 6.26 2.03 0.30 0.07 0.19
Divestitures
- 0.00 0.00 0.00 65 0.00 0.10 0.00
Net Cash From Financing Activities
-19 505 622 11 20 121 35 28
Net Cash From Continuing Financing Activities
-19 505 622 11 20 121 35 28
Repayment of Debt
-26 -31 0.00 -257 -6.25 -22 -42 -2.77
Issuance of Debt
28 123 375 266 0.00 0.00 46 11
Issuance of Preferred Equity
23 418 244 0.00 0.00 140 31 20
Other Financing Activities, net
0.00 0.00 3.73 1.85 0.29 2.48 0.01 0.00
Effect of Exchange Rate Changes
0.93 0.51 - 0.14 -2.24 -0.02 0.03 -0.13
Cash Interest Paid
0.50 0.98 4.67 11 3.00 0.81 8.58 0.36
Cash Income Taxes Paid
0.04 0.99 0.67 1.11 0.00 0.03 0.03 0.04

Quarterly Cash Flow Statements for Uxin

No quarterly cash flow statements for Uxin are available.


Annual Balance Sheets for Uxin

This table presents Uxin's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets
813 1,070 773 372 188 197 105 289
Total Current Assets
752 971 710 314 127 138 41 31
Cash & Equivalents
45 117 69 48 29 20 14 3.23
Restricted Cash
248 147 102 64 6.25 1.31 0.09 0.08
Note & Lease Receivable
106 81 227 59 27 8.66 0.00 0.00
Accounts Receivable
138 110 77 45 37 26 2.35 2.79
Inventories, net
12 2.82 1.98 1.45 11 67 16 15
Prepaid Expenses
38 61 23 19 16 14 8.94 9.94
Plant, Property, & Equipment, net
24 29 16 12 4.46 5.45 9.28 10
Total Noncurrent Assets
37 70 47 45 56 54 54 248
Long-Term Investments
24 51 39 39 44 46 42 39
Noncurrent Note & Lease Receivables
- - - - - - 0.00 186
Other Noncurrent Operating Assets
- 0.00 6.52 4.84 13 8.45 12 23
Total Liabilities & Shareholders' Equity
813 1,070 773 372 188 197 105 289
Total Liabilities
776 725 706 701 491 353 189 309
Total Current Liabilities
666 651 430 432 174 205 88 123
Short-Term Debt
65 264 84 69 12 37 26 51
Accounts Payable
10 23 18 19 26 15 12 11
Accrued Expenses
142 164 187 165 136 106 49 51
Other Current Liabilities
409 67 67 136 0.37 47 1.12 8.79
Total Noncurrent Liabilities
110 74 276 269 317 148 101 186
Long-Term Debt
57 70 275 269 281 129 81 0.00
Other Noncurrent Operating Liabilities
53 2.82 1.48 0.26 36 19 20 186
Commitments & Contingencies
0.00 - - - 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
1,292 - - - 0.00 83 101 21
Total Equity & Noncontrolling Interests
-1,255 345 67 -329 -304 -238 -185 -41
Total Preferred & Common Equity
-1,248 346 67 -329 -304 -238 -185 -41
Preferred Stock
- - - - - - - 0.00
Total Common Equity
-1,248 346 67 -329 -304 -238 -185 -41
Common Stock
0.00 1,888 1,877 1,830 2,083 2,249 2,250 2,627
Retained Earnings
-1,259 -1,555 -1,819 -2,175 -2,420 -2,532 -2,468 -2,684
Accumulated Other Comprehensive Income / (Loss)
12 13 9.79 15 33 46 32 31
Other Equity Adjustments
- - - - - 0.00 - -15
Noncontrolling Interest
-7.74 -0.36 -0.58 -0.02 -0.02 -0.03 -0.03 -0.03

Quarterly Balance Sheets for Uxin

No quarterly balance sheets for Uxin are available.


Annual Metrics and Ratios for Uxin

This table displays calculated financial ratios and metrics derived from Uxin's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - - - -
Revenue Growth
0.00% -59.88% 102.24% 137.67% 137.67% 0.00% 158.11% 16.18% -36.50%
EBITDA Growth
0.00% 3.23% 3.83% 12.48% 12.48% 38.85% 56.43% -18.10% 22.91%
EBIT Growth
0.00% 1.34% 2.23% 5.87% 5.87% 42.37% 55.59% -15.85% 18.80%
NOPAT Growth
0.00% 66.81% -507.99% 48.78% 48.78% 54.69% 47.65% -18.11% 16.72%
Net Income Growth
0.00% -111.10% 46.90% -27.62% -27.62% 0.00% 64.74% 11.59% -156.25%
EPS Growth
0.00% 16.95% 0.00% 0.00% -89.61% 0.00% 0.00% 11.59% 78.36%
Operating Cash Flow Growth
0.00% -196.86% -17.98% 48.37% 48.37% 0.00% 21.92% 72.56% 0.60%
Free Cash Flow Firm Growth
0.00% 0.00% -599.65% 69.73% 110.65% -145.74% 30.74% 6.43% 12.81%
Invested Capital Growth
0.00% 0.00% 205.64% 26.92% -313.66% 27.41% 37.22% 42.09% 67.73%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - -
Gross Margin
35.31% 70.00% 36.45% 56.59% 56.59% -2.48% 2.92% 1.24% 5.86%
EBITDA Margin
-161.27% -388.95% -184.95% -68.11% -68.11% -94.97% -16.03% -16.30% -19.79%
Operating Margin
-151.84% -125.59% -377.56% -81.37% -81.37% -84.06% -17.05% -17.33% -22.73%
EBIT Margin
-167.64% -412.20% -199.28% -78.92% -78.92% -103.71% -17.85% -17.80% -22.76%
Profit (Net Income) Margin
-168.94% -888.87% -233.40% -125.32% -125.32% -64.07% -8.75% -6.66% -26.88%
Tax Burden Percent
100.83% 215.99% 113.72% 146.28% 292.57% 57.50% 99.94% 93.23% 98.48%
Interest Burden Percent
99.95% 99.84% 102.99% 108.55% 217.10% 107.45% 49.08% 40.15% 119.96%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% -5,723.02% -68.97% -305.90% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% -5,738.91% 812.10% -758.42% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 5,605.75% -69.75% -3,261.87% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
0.00% -1,149.61% -117.26% -138.71% -3,349.98% 20.25% 9.85% 16.69% 98.47%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% -347.43% -92.69% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% -24.05% -20.31% -19.53% -24.97% -37.08% -23.93% -35.34% -22.00%
Return on Assets (ROA)
0.00% -51.86% -23.78% -31.01% -39.65% -22.91% -11.74% -13.23% -25.99%
Return on Common Equity (ROCE)
0.00% 39,108.64% 277.02% -139.03% -3,436.02% 20.25% 11.63% 29.55% 214.05%
Return on Equity Simple (ROE_SIMPLE)
0.00% 33.79% -64.79% -424.18% 86.81% 21.11% 9.49% 10.77% 126.19%
Net Operating Profit after Tax (NOPAT)
-126 -42 -254 -130 -130 -59 -31 -36 -30
NOPAT Margin
-106.29% -87.91% -264.29% -56.96% -56.96% -58.84% -11.93% -12.13% -15.91%
Net Nonoperating Expense Percent (NNEP)
0.00% -392.14% 15.89% -881.07% 905.05% 2.50% -5.26% -21.86% 68.82%
Cost of Revenue to Revenue
64.69% 30.00% 63.55% 43.41% 43.41% 102.48% 97.08% 98.76% 94.14%
SG&A Expenses to Revenue
70.79% 125.86% 162.41% 25.32% 25.32% 42.28% 9.23% 7.99% 12.90%
R&D to Revenue
20.35% 0.00% 18.89% 8.82% 8.82% 11.28% 2.21% 1.83% 2.46%
Operating Expenses to Revenue
187.15% 195.59% 412.67% 137.96% 137.96% 81.58% 19.97% 18.57% 28.59%
Earnings before Interest and Taxes (EBIT)
-198 -196 -191 -180 -180 -104 -46 -53 -43
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-191 -184 -177 -155 -155 -95 -41 -49 -38
Valuation Ratios
- - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 35.16 9.85 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 37.22 10.06 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.90 4.74 126.65 2.91 1.26 3.53 1.48 0.30 0.52
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% -99.25% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 72.54 3.78 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 27.73 125.50 3.49 2.07 5.66 2.19 0.81 0.68
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 11.40 0.00 0.00 2.33 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - -
Debt to Equity
0.00 3.35 0.97 5.38 -2.05 -0.97 -1.07 -1.27 -2.59
Long-Term Debt to Equity
0.00 1.57 0.20 4.11 -1.63 -0.93 -0.83 -0.96 0.00
Financial Leverage
0.00 -5.28 -0.98 -0.09 8.60 -0.66 -0.68 -0.63 -0.58
Leverage Ratio
0.00 22.17 4.93 4.47 179.98 -0.88 -0.84 -1.26 -3.79
Compound Leverage Factor
0.00 22.13 5.08 4.86 195.36 -0.95 -0.41 -0.51 -4.54
Debt to Total Capital
0.00% 77.02% 49.17% 84.32% 7,574.73% -2,781.89% 1,566.99% 466.98% 163.02%
Short-Term Debt to Total Capital
0.00% 41.04% 38.85% 19.82% 1,555.43% -114.88% 347.51% 113.52% 163.02%
Long-Term Debt to Total Capital
0.00% 35.97% 10.33% 64.50% 6,019.30% -2,667.01% 1,219.48% 353.46% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 804.90% -0.05% -0.14% -0.24% 0.24% 784.98% 441.72% 65.96%
Common Equity to Total Capital
0.00% -781.91% 50.88% 15.81% -3,687.12% 2,881.66% -2,251.97% -808.69% -128.99%
Debt to EBITDA
0.00 -0.67 -1.88 -2.31 -2.18 -3.09 -4.01 -2.19 -1.36
Net Debt to EBITDA
0.00 1.05 0.62 -0.85 -1.19 -2.25 -2.38 -1.05 -0.25
Long-Term Debt to EBITDA
0.00 -0.31 -0.40 -1.77 -1.73 -2.96 -3.12 -1.66 0.00
Debt to NOPAT
0.00 -2.95 -1.32 -2.77 -2.60 -4.98 -5.38 -2.94 -1.69
Net Debt to NOPAT
0.00 4.65 0.44 -1.02 -2.85 -3.63 -3.20 -1.41 -0.31
Long-Term Debt to NOPAT
0.00 -1.38 -0.28 -2.12 -2.07 -4.77 -4.19 -2.23 0.00
Altman Z-Score
0.00 -2.60 7.89 -2.77 -9.31 -19.22 -17.18 -32.09 -13.01
Noncontrolling Interest Sharing Ratio
0.00% 3,501.89% 336.24% -0.23% -2.17% 0.01% -18.09% -77.02% -117.37%
Liquidity Ratios
- - - - - - - - -
Current Ratio
0.00 1.13 1.49 1.65 1.46 0.73 0.67 0.47 0.26
Quick Ratio
0.00 0.43 0.67 0.91 0.70 0.54 0.27 0.18 0.05
Cash Flow Metrics
- - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 115 -577 -175 203 -93 -64 -60 -52
Operating Cash Flow to CapEx
-792.42% -2,283.50% -1,808.11% -37,211.02% -74,422.03% 0.00% -5,038.83% -767.97% -2,314.54%
Free Cash Flow to Firm to Interest Expense
0.00 3,779.14 -62.01 -10.80 12.55 -6.36 -9.89 -17.20 -6.05
Operating Cash Flow to Interest Expense
0.00 -9,217.16 -35.71 -10.61 -21.21 -11.70 -20.50 -10.46 -4.19
Operating Cash Flow Less CapEx to Interest Expense
0.00 -9,620.80 -37.69 -10.63 -10.63 -11.56 -20.90 -11.82 -4.37
Efficiency Ratios
- - - - - - - - -
Asset Turnover
0.00 0.06 0.10 0.25 0.32 0.36 1.34 1.99 0.97
Accounts Receivable Turnover
0.00 0.34 0.77 2.43 2.93 2.44 8.18 20.92 74.04
Inventory Turnover
0.00 1.19 8.25 41.23 46.37 17.03 6.44 7.10 11.40
Fixed Asset Turnover
0.00 1.97 3.62 10.18 11.04 11.94 52.12 40.72 19.47
Accounts Payable Turnover
0.00 1.41 3.71 4.82 4.79 4.60 12.36 22.48 15.63
Days Sales Outstanding (DSO)
0.00 1,062.76 472.92 150.05 124.64 149.71 44.62 17.45 4.93
Days Inventory Outstanding (DIO)
0.00 306.77 44.25 8.85 7.87 21.43 56.68 51.39 32.02
Days Payable Outstanding (DPO)
0.00 258.57 98.29 75.80 76.22 79.32 29.54 16.23 23.35
Cash Conversion Cycle (CCC)
0.00 1,110.97 418.88 83.10 56.29 91.82 71.77 52.60 13.61
Capital & Investment Metrics
- - - - - - - - -
Invested Capital
0.00 -157 166 211 -124 -90 -56 -33 -11
Invested Capital Turnover
0.00 -0.60 21.65 1.21 5.37 -0.94 -3.53 -6.72 -8.80
Increase / (Decrease) in Invested Capital
0.00 -157 323 45 -333 34 33 24 22
Enterprise Value (EV)
0.00 1,316 12,039 795 473 566 564 242 130
Market Capitalization
225 225 12,150 663 288 353 383 89 100
Book Value per Share
$0.00 ($25.30) $0.72 $0.08 ($2.59) ($0.34) ($0.21) ($0.16) ($0.03)
Tangible Book Value per Share
$0.00 ($25.57) $0.68 $0.07 ($2.60) ($0.34) ($0.21) ($0.16) ($0.03)
Total Capital
0.00 160 679 426 8.93 -11 11 23 31
Total Debt
0.00 123 334 359 338 293 166 107 51
Total Long-Term Debt
0.00 57 70 275 269 281 129 81 0.00
Net Debt
0.00 -194 -110 132 185 214 99 51 9.27
Capital Expenditures (CapEx)
12 12 18 0.46 0.46 -1.97 2.65 4.76 1.57
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -141 190 177 -162 -71 -52 -34 -43
Debt-free Net Working Capital (DFNWC)
0.00 152 584 365 -48 -36 -30 -21 -40
Net Working Capital (NWC)
0.00 86 320 280 -118 -48 -67 -47 -91
Net Nonoperating Expense (NNE)
74 380 -30 156 156 5.23 -8.21 -16 21
Net Nonoperating Obligations (NNO)
0.00 -194 -179 144 205 214 99 51 9.27
Total Depreciation and Amortization (D&A)
7.53 11 14 25 25 8.74 4.68 4.49 5.65
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -297.86% 198.20% 77.59% -71.15% -71.25% -20.02% -11.50% -22.74%
Debt-free Net Working Capital to Revenue
0.00% 320.07% 608.35% 159.89% -21.12% -35.70% -11.69% -6.97% -21.00%
Net Working Capital to Revenue
0.00% 182.01% 333.31% 122.86% -51.57% -47.80% -25.93% -15.64% -47.92%
Earnings Adjustments
- - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($73.00) ($21.00) ($0.22) $0.00 $0.00 $0.00 ($0.02)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 8.81M 1.27M 127.30M 11.01M 11.68M 134.45M 2.19B
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($73.00) ($11.00) ($0.11) $0.00 $0.00 $0.00 ($0.02)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 8.81M 1.27M 127.30M 13.31M 13.55M 134.45M 2.19B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 4.78M 8.87M 127.30M 11.25M 11.92M 141.23M 56.40B
Normalized Net Operating Profit after Tax (NOPAT)
-126 -42 -254 -130 -130 -59 -31 -36 -30
Normalized NOPAT Margin
-106.29% -87.91% -264.29% -56.96% -56.96% -58.84% -11.93% -12.13% -15.91%
Pre Tax Income Margin
-167.55% -411.54% -205.24% -85.67% -85.67% -111.44% -8.76% -7.15% -27.30%
Debt Service Ratios
- - - - - - - - -
EBIT to Interest Expense
0.00 -6,403.14 -20.56 -11.13 -22.26 -7.11 -7.08 -15.26 -5.00
NOPAT to Interest Expense
0.00 -1,365.64 -27.27 -8.03 -16.07 -4.03 -4.74 -10.40 -3.49
EBIT Less CapEx to Interest Expense
0.00 -6,806.78 -22.54 -11.16 -22.32 -6.97 -7.49 -16.62 -5.18
NOPAT Less CapEx to Interest Expense
0.00 -1,769.28 -29.24 -8.06 -16.12 -3.90 -5.14 -11.76 -3.68
Payout Ratios
- - - - - - - - -
Dividend Payout Ratio
0.00% -1.06% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-21.97% -1.06% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics and Ratios for Uxin

No quarterly metrics and ratios for Uxin are available.


Frequently Asked Questions About Uxin's Financials

When does Uxin's financial year end?

According to the most recent income statement we have on file, Uxin's fiscal year ends in March. Their fiscal year 2024 ended on March 31, 2024.

How has Uxin's net income changed over the last 7 years?

Uxin's net income appears to be on a downward trend, with a most recent value of -$51.18 million in 2024, falling from -$199.73 million in 2016. The previous period was -$19.97 million in 2023.

What is Uxin's operating income?
Uxin's total operating income in 2024 was -$43.28 million, based on the following breakdown:
  • Total Gross Profit: $11.16 million
  • Total Operating Expenses: $54.44 million
How has Uxin revenue changed over the last 7 years?

Over the last 7 years, Uxin's total revenue changed from $118.22 million in 2016 to $190.40 million in 2024, a change of 61.0%.

How much debt does Uxin have?

Uxin's total liabilities were at $309.02 million at the end of 2024, a 63.7% increase from 2023, and a 60.2% decrease since 2017.

How much cash does Uxin have?

In the past 7 years, Uxin's cash and equivalents has ranged from $3.23 million in 2024 to $116.59 million in 2018, and is currently $3.23 million as of their latest financial filing in 2024.

How has Uxin's book value per share changed over the last 8 years?

Over the last 8 years, Uxin's book value per share changed from 0.00 in 2016 to -0.03 in 2024, a change of -2.9%.



This page (NASDAQ:UXIN) was last updated on 4/29/2025 by MarketBeat.com Staff
From Our Partners